Taking advantage of years of research and development and
experience engaged in the treatment of cancer immune cells

DC Vaccine Therapy (Th1 activation-type) (JPN Pat. No. 5816550) provided at our clinic is a revolutionary therapy based on a patent for which technology has succeeded in improving culture method by research and development for many years. Th1 activation-type refers to eliciting a good immunity state that is expected to be most effective by stimulating proliferation and activation of Th1 type cells.
Th1 type cells have the cellular immunity inducing ability indispensable for the proliferation and activation of the most important cytotoxic T cells for cancer treatment.
There are other treatment menus including αβ T cell therapy, NK cell therapy, AKT - DC therapy, NKT cell target therapy.

Registered Medical Institution Reported by the Ministry of Health, Labor and Welfare in Compliance with the Law Concerning the Security of Regenerative Medicine

Tel / Opening hours

Please feel free to contact us for any problems or concerns.

Opening Hours Mon. Tue. Wed. Thu. Fri. Sat.
10:00-13:30
16:00-18:30